mHealth India Postnatal Health Intervention Effectiveness

Launched by UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · Feb 24, 2022

Keywords

ClinConnect Summary

This clinical trial, called the mHealth India Postnatal Health Intervention Effectiveness study, is looking to see how effective a mobile phone-based education and support program is for new mothers in India. The program aims to provide helpful information and support about health practices after giving birth, such as breastfeeding, nutrition, and managing postpartum depression. Researchers will compare the outcomes of women who receive this mobile support along with standard postpartum care to those who only receive the usual care. The study involves 2,100 women across three different states in India and will analyze how this program impacts their health knowledge, behaviors, and overall health.

To participate in this trial, women need to be between 28 and 32 weeks pregnant, speak the local language, and either have their own mobile phone or be willing to use a study phone. They must also be able to understand and agree to participate in the study. If eligible, participants can expect to receive valuable information and support through their phones, helping them improve their health and well-being after childbirth. The study is currently recruiting participants, and it aims not only to assess health outcomes but also to understand how knowledge, social support, and confidence can lead to positive changes in health behaviors.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Pregnant (28-32 weeks gestational age)
• • Speak local language
• • Personal mobile phone or willing to accept study phone
• • Able to provide informed consent
• Exclusion Criteria:
• • Do not speak local language
• • No personal phone or unwilling to accept study phone
• • Unable to provide informed consent